4,5-dihydroxy-5-methyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione (123715-12-8)

Identification
Name:	4,5-dihydroxy-5-methyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
Synonyms:	Aucherine;AC1L46QB;123715-12-8
CAS:	123715-12-8
Molecular Formula:	C₁₇H₂₅NO₆
Molecular Weight:	339.3835
InChI:	InChI=1/C17H25NO6/c1-9(2)12-14(19)17(3,22)16(21)23-8-10-4-6-18-7-5-11(13(10)18)24-15(12)20/h4,9,11-14,19,22H,5-8H2,1-3H3
Molecular Structure:
Properties
Flash Point:	287.3°C
Boiling Point:	551.4°C at 760 mmHg
Density:	1.32g/cm³
Refractive index:	1.576
Flash Point:	287.3°C
Safety Data

Other Product

(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-5-[(1R)-1-hydroxyethyl]-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(3R,4R,5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,5-ethyl-4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3-(1-methylethyl)-,(5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine- 2,6(3H)-dione,4,5,8,10,12,13,13a,13boctahydro- 4,5-dihydroxy-5-(hydroxymethyl)- 4-methyl-3-(1-methylethyl)-,(3R,4R,5R,- 13aR,13bR)-
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
5-(1-hydroxyethyl)-3,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
8H,11H-Oxeto[2',3':9,10][1,6]dioxacycloundecino- [2,3,4-gh]pyrrolizine-8,12(9H)-dione,1,2,4,6,- 9a,11a,13a,13b-octahydro-,(9R,9aR,11aR,- 13aR,13bR)-
4-hydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione 11-oxide
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-5-hydroxy-3,4,5-trimethyl-,(3R,4S,5R,13aR,13bR)- (9CI)
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4-hydroxy-3,4,5-trimethyl-,(3R,4S,5S,13aR,13bR)- (9CI)
Butanoic acid,2-methyl-,(3R,4S,5R,13aR,13bR)-3,4,5,6,8,10,12,13,13a,13b-decahydro-5-hydroxy-3,4,5-trimethyl-2,6-dioxo-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizin-4-ylester, (2R)- (9CI)
(3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione hydrochloride (1:1)
(13aR,13bR)-4,4-dimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H
1/C12H24O2Te/c1-14-12(13)10-8-6-4-3-5-7-9-11-15-2/h3-11H2,1-2H
1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
1/C8H10N4OS/c1-5-4-6(13)12-8(11(5)2)9-7(10-12)14-3/h4H,1-3H
Spiro[[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-3(2H),2'-oxirane]-2,7(4H)-dione,5,6,9,11,13,14,14a,14b-octahydro-6-hydroxy-3',6-dimethyl-5-methylene-,(2'S,3'S,6R,14aR,14bR)-
1/C12H15N/c1-3-6-10-9(2)13-12-8-5-4-7-11(10)12/h4-5,7-8,13H,3,6H2,1-2H
2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,(3R,4R,5R,13aR,13bR)-